FDA Releases Guidance on Premarket Notifications for Magnetic Resonance Diagnostic Devices

Summary

The Food and Drug Administration (FDA) has made available a new guidance document outlining the requirements for submitting premarket notifications for magnetic resonance diagnostic devices, a key step in the regulatory process for these medical devices.